Trilogy Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Trilogy Capital's MDT Position: Q3 2026 in Review
Trilogy Capital increased its Medtronic (MDT) stake by 9% in Q3 2026, buying an estimated $327K and bringing the position to 45,029 shares worth $3.89M. The position accounts for 0.15% of the portfolio, ranked #114.
Trilogy Capital first reported a position in MDT in Q1 2018 and has held it in 16 quarters since. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Trilogy Capital held 45,029 shares of Medtronic worth $3.89M as of Q3 2026.
- Trilogy Capital bought 3,707 Medtronic shares in Q3 2026, an estimated $327K.
- Medtronic made up 0.15% of Trilogy Capital's portfolio in Q3 2026, its #114 holding.
- Trilogy Capital first reported a position in Medtronic in Q1 2018 and has held it in 16 quarters since.
- 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.